Samuraciclib
Small moleculeexperimental
Clinical trial activity
5 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
5
Phase 3
0
Phase 4
0
Earliest trial started Nov 14, 2017 (NCT03363893)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05963984 | Phase 2 | Dec 14, 2023 | Carrick Therapeutics Limited, Pfizer |
| NCT06125522 | Phase 2 | Nov 10, 2023 | Arvinas Inc, Carrick Therapeutics Limited, Pfizer |
| NCT05963997 | Phase 1/Phase 2 (Phase 2) | Oct 9, 2023 | Carrick Therapeutics Limited, Menarini Group |
| NCT04802759 | Phase 1/Phase 2 (Phase 2) | Jun 20, 2021 | Roche |
| NCT03363893 | Phase 1/Phase 2 (Phase 2) | Nov 14, 2017 | Carrick Therapeutics Limited, The Christie NHS Foundation Trust |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Carrick Therapeutics Limited | For profit | 4 | 3 | 1 | 2017 |
| Pfizer | For profit | 2 | 1 | 1 | 2023 |
| Arvinas Inc | For profit | 1 | 0 | 1 | 2023 |
| Menarini Group | For profit | 1 | 0 | 1 | 2023 |
| Roche | For profit | 1 | 1 | 1 | 2021 |
| The Christie NHS Foundation Trust | Academic/Hospital | 1 | 0 | 1 | 2017 |
6 organizations
Page 1 / 1